Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
 Blood, 1 March 2005, Vol. 105, No. 5, pp. 2124-2131.
Prepublished online as a Blood First Edition Paper on November 4, 2004; DOI 10.1182/blood-2004-07-2683.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2004-07-2683v1
105/5/2124    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Libura, J.
Right arrow Articles by Richardson, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Libura, J.
Right arrow Articles by Richardson, C.
Related Collections
Right arrow Oncogenes and Tumor Suppressors
Right arrow Gene Expression
Right arrow Neoplasia
Right arrowRelated Article in Blood Online
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

NEOPLASIA

Therapy-related acute myeloid leukemia–like MLL rearrangements are induced by etoposide in primary human CD34+ cells and remain stable after clonal expansion

Jolanta Libura, Diana J. Slater, Carolyn A. Felix, and Christine Richardson

From the Institute of Cancer Genetics, Department of Pathology, Columbia University College of Physicians and Surgeons, New York, NY; the Division of Oncology, Children's Hospital of Philadelphia, PA; and the Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia.

Rearrangements involving the MLL gene on chromosome band 11q23 are a hallmark of therapy-related acute myeloid leukemias following treatment with topoisomerase II poisons including etoposide. Therapy-related and de novo genomic translocation breakpoints cluster within a well-characterized 8.3-kb fragment of MLL. Repair of etoposide-stabilized DNA topoisomerase II covalent complexes may initiate MLL rearrangements observed in patients. We used a culture system of primary human hematopoietic CD34+ cells and inverse polymerase chain reaction to characterize the spectrum of stable genomic rearrangements promoted by etoposide exposure originating within an MLL translocation hotspot in therapy-related leukemia. Alterations to the region were observed at a readily detectable frequency in etoposide-treated cells. Illegitimate repair events after minimal repair included MLL tandem duplications and translocations, with minor populations of deletions or insertions. In stably repaired cells that proliferated for 10 to 14 days, the significant majority of illegitimate events were MLL tandem duplications, and several deletions, inversions, insertions, and translocations. Thus, etoposide promotes specific rearrangements of MLL consistent with the full spectrum of oncogenic events identified in leukemic samples. Although etoposide-initiated rearrangements are frequent, only a small subset of translocations occurs in cells that proliferate significantly.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article in Blood Online:

"You break it, you fix it"
Peter D. Aplan
Blood 2005 105: 1843-1844. [Full Text] [PDF]



This article has been cited by other articles:


Home page
 The OncologistHome page
M. A. Lichtman
Is There an Entity of Chemically Induced BCR-ABL-Positive Chronic Myelogenous Leukemia?
Oncologist, June 1, 2008; 13(6): 645 - 654.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
S. B. van Waalwijk van Doorn-Khosrovani, J. Janssen, L. M. Maas, R. W.L. Godschalk, J. G. Nijhuis, and F. J. van Schooten
Dietary flavonoids induce MLL translocations in primary human CD34+ cells
Carcinogenesis, August 1, 2007; 28(8): 1703 - 1709.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
J. D. Dickerman
The Late Effects of Childhood Cancer Therapy
Pediatrics, March 1, 2007; 119(3): 554 - 568.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
C. G. Moneypenny, J. Shao, Y. Song, and E. P. Gallagher
MLL rearrangements are induced by low doses of etoposide in human fetal hematopoietic stem cells
Carcinogenesis, April 1, 2006; 27(4): 874 - 881.
[Abstract] [Full Text] [PDF]


click for free articles
home about blood authors subscriptions permissions advertising public access contact us
Sponsor: Genentech BioOncology and and Biogen Idec
Blood Online is supported in part by
Genentech BioOncology and Biogen Idec
  Copyright © 2005 by American Society of Hematology         Online ISSN: 1528-0020